Department of Ayurveda, Regional Ayurveda Research Institute, C.C.R.A.S, Gwalior, India
Research
Comprehensive Review of the Therapeutic Potential of Ayush−64 against Covid−19
Author(s): Shyam Babu Singh*, Poornima Mansoria and Savita Sharma
The global pandemic of the corona virus disease (COVID-19) has caused widespread morbidity and mortality globally. The complicated
pathophysiology of COVID-19 and lack of a single therapy have made management a significant issue. Through comprehensive pharmacological,
toxicological and clinical research, AYUSH-64, a poly-herbal formulation developed by CCRAS, Ministry of AYUSH, Government of India, has
demonstrated both its safety and effectiveness in treating infective febrile illnesses like malaria and influenza. Four components in AYUSH-64
include antiviral, immunomodulatory, anti-inflammatory, antipyretic and anti-inflammatory properties. In COVID-19, it stops the inflammatory
responses that lead to substantial morbidity. The Government of India has also included AYUSH-64 in the National COVID management protocol
based on Ayurveda and Yoga for asymptomatic .. Read More»
DOI:
10.37421/2327-5162.2023.12.432
Alternative & Integrative Medicine received 476 citations as per Google Scholar report